On Wednesday, April 6, the Health, Education, Labor, and Pensions (HELP) Committee held the last in a series of three markups on the so-called Innovation for Healthier Americans Initiative. A separate bill sponsored by Sen. Joe Casey (D-PA) to incentivize the development of new treatments for newborns - the Promoting Life-Saving New Therapies for Neonates Act (S. 2041) - was submitted via an amendment from one of the bill's primary sponsors, Sen. Bill Cassidy (R-LA). The newborn health amendment was submitted during the markup, one of a separate bill (S. 2700) related to the Food and Drug Administration (FDA) and National Institutes of Health (NIH) workforce.
Sen. Cassidy – one of a handful of physicians serving in Congress – spoke powerfully on the dire need for new treatments for newborns and how his bill would help spur the innovation needed to help bring neonatal drug therapies into the 21st Century.
Sen. Cassidy – one of a handful of physicians serving in Congress – spoke powerfully on the dire need for new treatments for newborns and how his bill would help spur the innovation needed to help bring neonatal drug therapies into the 21st Century.
